Supervised Undergraduate Thesis (SUPT20HL2) (G170067)

Target Name: SUPT20HL2

NCBI ID: G170067

Supervised Undergraduate Thesis (SUPT20HL2)

SUPT20HL2 is a protein that is expressed in various tissues of the human body, including the brain, heart, and blood vessels. It is a key regulator of the cell cycle, and its levels have been linked to the development and progression of many diseases, including cancer. In this article, we will explore the potential implications of SUPT20HL2 as a drug target or biomarker.

Drug Target Potential

SUPT20HL2 has been identified as a potential drug target due to its involvement in the regulation of cell division and its role in the development of cancer. Many studies have shown thatSUPT20HL2 is highly expressed in various types of cancer, including neurobladder cancer, breast cancer, and colon cancer. Additionally, SUPT20HL2 has been shown to promote the growth and survival of cancer cells in cell culture and animal models.

One potential mechanism by which SUPT20HL2 could be used as a drug target is its role in the regulation of the cell cycle. The cell cycle is the process by which cells grow, divide, and replicate their genetic material.SUPT20HL2 is a key regulator of the cell cycle, and its levels have been shown to be reduced in cancer cells compared to normal cells. This reduction inSUPT20HL2 levels could make it an attractive target for drugs that aim to inhibit cell division or disrupt the cell cycle.

Another potential mechanism by which SUPT20HL2 could be used as a drug target is its role in the development of cancer.SUPT20HL2 has been shown to promote the growth and survival of cancer cells in cell culture and animal models. This increase inSUPT20HL2 levels could make it an attractive target for drugs that aim to inhibit the growth and survival of cancer cells.

Biomarker Potential

SUPT20HL2 has also been identified as a potential biomarker for the development and progression of cancer. The levels of SUPT20HL2 have been shown to be elevated in the blood and other body fluids of individuals with various types of cancer. This increase inSUPT20HL2 levels could be used as a biomarker to monitor the progression of cancer and the response to treatments.

Conclusion

In conclusion, SUPT20HL2 is a protein that has been shown to be involved in the regulation of the cell cycle and the development and progression of cancer. Its potential as a drug target or biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of SUPT20HL2 in the regulation of cell division and the development and progression of cancer.

Protein Name: SUPT20H Like 2

More Common Targets